[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fllpSUvubLKWcdr9wAyNuK0WiIA3iIS3bg4-Q5DaqrlA":8,"$fZFRe4onm_rWLcVWPvFhW2R4dydLCSc6MxY6OY_owYhM":61,"$fLZjiia3g--CDqIA7oUmOICTUHoA6G3xu6qLHSIjiNeE":62,"$fC-MdQNjOl3OXnuGLR_agBt9Oot5uXvT5Nmw08XpczMA":66},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":60},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"roleType":17,"adept":18,"hospital":19,"department":20,"postsTitle":21,"materialTotal":17,"videoTotal":22,"isConcern":7,"title":23,"coverVertical":24,"coverAcross":25,"directionMarker":26,"description":27,"vid":28,"time":29,"mediaType":30,"views":31,"likes":17,"isThumbsUp":7,"isCollection":7,"collections":17,"createTime":32,"seoTitle":33,"seoKeywords":34,"seoDescription":35,"shelvesTime":36,"menus":37,"menuId":39,"type":26,"quality":57,"commentCount":17,"isComment":30,"deviceType":58,"url":59},6999,863398,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//W6OyePPo6ps051zACW5hlRIUH6DBCgnt.png","刘芬",0,"各种肿瘤的诊治","宁乡市人民医院","肿瘤科","主治医师",13,"79岁女性结肠癌III期患者的靶向治疗：贝伐珠单抗的关键作用","https://cdn.yishi-tong.com/console/3/8RUQuOokmmy1JLks0iaypUEn8yo6zYyE.png","https://cdn.yishi-tong.com/console/3/m5NgKx1DDA1Tw_n8tub73SRfAmRDMCHZ.png",2,"\n\n大家好，我是宁乡市人民医院肿瘤科的刘芬医生。今天我想和大家分享一个关于结肠癌III期患者的真实案例，以及靶向治疗在其中的重要作用。\n\n这位患者是一位79岁的女性，来自湖南省长沙市。她的生活习惯良好，没有不良嗜好，过敏史也为零。然而，她在近期被诊断为结肠癌III期，具体为pT3N1M0，且在手术后复发，出现了肝、盆腔和脾脏的转移。患者同时还合并有高血压病3级、胃食管反流、骨髓抑制和低钾血症等多种健康问题。\n\n在入院期间，我们为她进行了全面的检查，结果显示她的肝肾功能和肿瘤标志物（如癌胚抗原CEA）等主要指标相对稳定。为了控制病情，我们决定采用贝伐珠单抗注射液进行靶向治疗。这种药物通过靶向肿瘤血管生成，能够有效抑制肿瘤的生长和转移。\n\n在住院的短短两天内，患者的身体状况得到了有效的监测和调整。出院时，她的精神状态、睡眠和食欲都保持在一般水平，虽然偶尔感到手足麻木，但没有明显的腹痛症状。我们为她制定了详细的出院医嘱，包括加强护理、避免受凉、适当饮食以及后续的治疗计划。\n\n靶向治疗的优势在于其针对性强，副作用相对较小，能够为患者提供更好的生活质量。尽管患者的病情复杂，但通过合理的治疗方案，她的身体状况得到了稳定。我们会继续密切关注她的血压和其他健康指标，确保她在后续治疗中能够得到及时的调整和支持。\n\n总之，结肠癌III期患者的治疗需要综合考虑多种因素，靶向治疗如贝伐珠单抗在其中发挥了重要的作用。希望通过这个案例，能够让更多人了解结肠癌的治疗选择，以及靶向药物在癌症治疗中的潜力。","v0247cg10004d1553piljht4boorcl3g",162,1,490,"2025-06-03 13:59:25","79岁女性结肠癌III期患者靶向治疗：贝伐珠单抗的关键作用与疗效分析  ","结肠癌III期, 贝伐珠单抗, 老年结肠癌治疗, 靶向治疗, 抗血管生成药物, 79岁患者, 癌症治疗方案  ","本文探讨贝伐珠单抗在79岁III期结肠癌患者治疗中的关键作用，解析靶向治疗机制、临床疗效及老年患者应用策略，为晚期结肠癌提供治疗参考。","2025-06-15 07:12:00",[38],{"menuId":39,"menuName":40,"parentId":17,"orderNum":41,"path":42,"component":43,"isFrame":44,"isCache":45,"menuType":46,"visible":30,"status":17,"createDept":6,"remark":47,"createTime":48,"children":49,"columnImage":50,"columnLogo":51,"uncheckedLogo":6,"checkedLogo":6,"isHot":17,"isHome":17,"forceLogin":17,"color":6,"seoTitle":52,"seoKeywords":53,"seoDescription":54,"contentNum":6,"promotionalPoster":55,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":56,"routerPath":42,"componentInfo":43},"1986622624134549505","科普视频",3,"video","/video.html","1","0","T","","2025-11-07 10:31:58",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:09:40/0d7fcb56-3dc4-4dcb-99ca-a5d5c438378e.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:09:43/958efac7-dd02-4681-b8fd-0dd84b1bbf42.png","健康科普视频大全,了解你的健康生活","健康科普视频, 戒烟视频, 饮食健康视频, 胸痛科普, 用药知识, 职业健康视频, 贫血科普, 眼健康视频","精选健康科普视频,涵盖戒烟、胸痛、饮食、用药与职业健康等多个主题,让你轻松获取科学健康知识,提升生活质量。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:09:45/fa8fe113-deaa-4454-8105-d629769963dd.png","Video","癌症肿瘤,重大疾病",4,"https://vod.haohuanjiao.com/huanjiao/specialistVideo/863398/3c8c9379-4086-414c-ab51-629255fe49b7.tmp?a=0&auth_key=1789003528-59ac5c7dd74d42eeb37413ec6cf6aec8-0-9ea2d8c0041ab14219ba65b34b3c8521&br=766&bt=766&cd=0%7C0%7C0&ch=0&cr=0&cs=0&dr=0&ds=3&eid=v0247cg10004d1553piljht4boorcl3g&er=0&l=20260810232241B96C4F909B58E41F78EB&lr=&mime_type=video_mp4&net=0&pl=0&qs=13&rc=am91cjdrb3M4NDczNGY3M0ApNmZyZXdtbDY4ZzMzajo1eWcwYGxfcWdmMDJhLS1kNC9zc2Rpb2wxZWltMi4xLS5gMS06Yw%3D%3D&vl=&vr=",true,{"code":9,"msg":59,"message":6,"data":6,"success":60},{"code":9,"msg":10,"message":6,"data":63,"success":60},{"pageNo":30,"pageSize":64,"result":65,"totalSize":17},10,[],{"code":9,"msg":10,"message":6,"data":67,"success":60},{"authors":68,"appraiseDimensionScoresVos":69},[],[]]